Search results for "Pathologic"

showing 10 items of 710 documents

ABH-antigenicity of transitional cell carcinoma of the urinary bladder in patients subjected to topical chemoprophylaxis

1983

Topical chemoprophylaxis with adriamycin was administered to 49 patients with UICC-stages pTA and PT1 (pathological stage 0 and A) of transitional cell carcinoma of the urinary bladder. Tumor specimens obtained prior to initiation of the instillation protocol were evaluated with regard to ABH-antigenicity. ABH-antigens were present in tumors of 19 patients and none of these developed muscle-infiltrating recurrences during or after intravesical chemoprophylaxis. The primary lesions of 30 patients were deleted of antigens; only 5 (16%) developed a progressive recurrence. Compared to a historical control group this is thought to be a true reduction of invasive tumor recurrences in ABH-negative…

Nephrologymedicine.medical_specialtyAntigenicityUrinary bladderbusiness.industryUrologyUrologymedicine.diseasemedicine.anatomical_structureTransitional cell carcinomaAntigenInternal medicineChemoprophylaxismedicineStage (cooking)businessPathologicalWorld Journal of Urology
researchProduct

Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions.

2015

Extracellular vesicles are involved in a great variety of physiological events occurring in the nervous system, such as cross talk among neurons and glial cells in synapse development and function, integrated neuronal plasticity, neuronal-glial metabolic exchanges, and synthesis and dynamic renewal of myelin. Many of these EV-mediated processes depend on the exchange of proteins, mRNAs, and noncoding RNAs, including miRNAs, which occurs among glial and neuronal cells. In addition, production and exchange of EVs can be modified under pathological conditions, such as brain cancer and neurodegeneration. Like other cancer cells, brain tumours can use EVs to secrete factors, which allow escaping…

Nervous systemectosomeCelllcsh:MedicineReview ArticleBiologyhorizontal transfer of pathological propertieGeneral Biochemistry Genetics and Molecular BiologySynapseExtracellular VesiclesMyelinextracellular membrane vesicles (EVs); ectosomes; exosomes; brain cancer; neuronal-glial unconventional cross-talk pathways; horizontal transfer of pathological properties; extracellular spreading of protein aggregates.Settore BIO/10 - BiochimicamedicineexosomeHumansSecretionextracellular membrane vesicles (EVs)Settore BIO/06 - Anatomia Comparata E CitologiaTransport Vesiclesbrain cancerNeuronsMembranesNeuronal PlasticityGeneral Immunology and Microbiologylcsh:RNeurodegenerationBrainBiological TransportGeneral Medicinemedicine.diseaseextracellular spreading of protein aggregates.Cell biologyMicroRNAsmedicine.anatomical_structureSynapsesCancer cellNeurogliaNeuroglianeuronal-glial unconventional cross-talk pathway
researchProduct

2021

Aging and diabetes lead to protein glycation and cause dysfunction of collagen-containing tissues. The accompanying structural and functional changes of collagen significantly contribute to the development of various pathological malformations affecting the skin, blood vessels, and nerves, causing a number of complications, increasing disability risks and threat to life. In fact, no methods of non-invasive assessment of glycation and associated metabolic processes in biotissues or prediction of possible skin complications, e.g., ulcers, currently exist for endocrinologists and clinical diagnosis. In this publication, utilizing emerging photonics-based technology, innovative solutions in mac…

New horizonsRadiological and Ultrasound Technologybusiness.industryHyperspectral imagingmedicine.diseaseMachine learningcomputer.software_genre3. Good health030218 nuclear medicine & medical imagingComputer Science Applications03 medical and health sciences0302 clinical medicineGlycationClinical diagnosisDiabetes mellitusMedicineArtificial intelligenceElectrical and Electronic EngineeringStage (cooking)businessProtein glycationPathologicalcomputerSoftwareIEEE Transactions on Medical Imaging
researchProduct

640-Slice CT Measurement of Superior Orbital Fissure as Gateway for Light into the Brain: Statistical Evaluation of Area and Distance.

2016

Objective Our aim was to provide normative data concerning superior orbital fissure area (SOFA), ocular skin and the substantia nigra (D-SS) and orbital fissure and the substantia nigra (D-SOF-S) distances by CT scan in adult Caucasian population. Methods The area of the superior orbital fissure (SOF), the distance between the ocular skin and the substantia nigra and the distance between the superior orbital fissure and the substantia nigra using CT and 3D-CT images. Results Normative data stratified for age and gender were obtained. The data here reported show that some degree of variability in SOFA, D-SS and D-SOF-S measurements can be observed healthy Caucasian subjects. Gender stratifie…

Normal Distributionlcsh:MedicineComputed tomographyDistance MeasurementNervous System030218 nuclear medicine & medical imagingDiagnostic RadiologyMidbrain0302 clinical medicineMedicine and Health SciencesMedicineCaucasian populationlcsh:ScienceTomographyMeasurementMultidisciplinaryMovement Disordersmedicine.diagnostic_testNervesOrbital fissureRadiology and ImagingCranial NervesBrainNeurodegenerative DiseasesParkinson DiseaseSubstantia Nigramedicine.anatomical_structureNeurologySuperior orbital fissurePhysical SciencesEngineering and TechnologyAnatomyBrainstemBright lightResearch ArticleImaging TechniquesOcular AnatomySubstantia nigraNeuroimagingResearch and Analysis MethodsMidbrain03 medical and health sciencesDiagnostic MedicineOcular SystemPathologicalbusiness.industrylcsh:RBiology and Life SciencesProbability TheoryProbability DistributionComputed Axial Tomographylcsh:QbusinessNuclear medicine030217 neurology & neurosurgeryMathematicsNeurosciencePloS one
researchProduct

Virus and Experimental Diabetes

1984

Special subtypes of viruses belonging to different virus families are known to be able to induce insulin-deficient diabetes or pathological glucose tolerance in experimental animals (Table 1). The development of the diabetogenic effect of viruses is dependent on the species (Table 1) and, within one species, dependent on age and sex (Friedman et al., 1972), particularly on the genetic factors of the animals determining susceptibility or resistance to diabetes (Craighead and Higgins, 1974; Yoon and Notkins, 1976).

Nude mouseDiabetes mellitusImmunologymedicineBiologyAge and sexmedicine.diseasebiology.organism_classificationPathologicalVirusVirus classificationExperimental diabetes
researchProduct

Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (pCR) after primary chemotherapy.

2009

Abstract Learning Objectives After completing this course, the reader will be able to: Summarize the main risk factors for relapse in patients with T4 breast cancer after neoadjuvant chemotherapy.Evaluate the role of hormone receptors and HER-2 as determinants of risk of relapse after neoadjuvant treatment.Compare the difference in outcomes between patients who achieve less than pCR in relation to receptor status. This article is available for continuing medical education credit at CME.TheOncologist.com. Purpose. Pathological complete response (pCR) to primary chemotherapy is the main determinant for improved disease-free survival (DFS) and overall survival (OS). The primary endpoints of ou…

OncologyAdultCancer Researchmedicine.medical_specialtyTime FactorsSettore MED/06 - Oncologia MedicaReceptor ErbB-2Breast NeoplasmsVinorelbineDisease-Free SurvivalBreast cancerTrastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansPathologicalMastectomyAgedNeoplasm StagingCisplatinStage IIIB breast cancerNeoadjuvant chemotherapyPathological responseLong-term outcomesbusiness.industryRadiotherapy DosageMiddle Agedmedicine.diseasePrognosisCombined Modality TherapySurvival RateRegimenTreatment OutcomeOncologyHormone receptorLymphatic MetastasisFemaleLymph Nodesbusinessmedicine.drugEpirubicinFollow-Up StudiesThe oncologist
researchProduct

Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy

2013

It is well-known that male breast cancer (MBC) susceptibility is mainly due to high-penetrance BRCA1/2 mutations. Here, we investigated whether common low-penetrance breast cancer (BC) susceptibility alleles may influence MBC risk in Italian population and whether variant alleles may be associated with specific clinicopathological features of MBCs. In the frame of the Italian Multicenter Study on MBC, we genotyped 413 MBCs and 745 age-matched male controls at 9 SNPs annotating known BC susceptibility loci. By multivariate logistic regression models, we found a significant increased MBC risk for 3 SNPs, in particular, with codominant models, for rs2046210/ESR1 (OR = 1.71; 95 % CI: 1.43–2.05;…

OncologyAdultMaleCancer Researchmedicine.medical_specialtyMultivariate analysisSettore MED/06 - Oncologia MedicaClinicopathological characteristicBRCA1/2; Clinicopathological characteristics; ER/PR status; Low-penetrance breast cancer alleles; Male breast cancer; SNPsSingle-nucleotide polymorphismPolymorphism Single NucleotideER/PR statuBreast Neoplasms MaleBreast cancerBRCA1/2Internal medicineGenotypemedicineHumansGenetic Predisposition to DiseaseAlleleReceptor Fibroblast Growth Factor Type 2Low-penetrance breast cancer alleleAllelesAgedAged 80 and overbusiness.industryEstrogen Receptor alphaHigh Mobility Group Proteinsclinicopathological characteristicsMiddle Agedmedicine.diseasePenetranceMale breast cancerer/pr statusOncologyTOX3ItalyReceptors EstrogenMale breast cancerCase-Control StudiesMultivariate AnalysisTrans-Activatorslow-penetrance breast cancer allelesbusinessApoptosis Regulatory ProteinsReceptors Progesteroneclinicopathological characteristics; er/pr status; male breast cancer; brca1/2; snps; low-penetrance breast cancer allelesSNPs
researchProduct

Study of axillary lymph node asymmetry in a female population

2001

We analysed a large series of axillary lymph nodes, with and without metastases following radical mastectomy for breast cancer. We found left/right asymmetry in numbers of lymph nodes, and also asymmetry of lymph node dimensions, which could have been the caused by tumoral antigenic stimulation. The distribution of hyperplastic node patterns differed significantly.

OncologyAdultmedicine.medical_specialtyPathologyHistologyAxillary lymph nodesmedicine.medical_treatmentTumoral antigenic stimulationBreast NeoplasmsFunctional LateralityBreast cancerBreast cancerInternal medicinemedicineHumansMolecular BiologyLymph nodeEcology Evolution Behavior and SystematicsRadical mastectomyMastectomyAgedBreast cancer; Histopathological changes; Hyperplasia; Mastectomy; Tumoral antigenic stimulation; Agricultural and Biological Sciences (miscellaneous); AnatomyHyperplasiabusiness.industryCell BiologyHyperplasiaMiddle Agedmedicine.diseaseAgricultural and Biological Sciences (miscellaneous)Histopathological changeAxillamedicine.anatomical_structureLymphatic MetastasisAxillaFemaleLymphLymph NodesAnatomybusinessMastectomy RadicalMastectomyDevelopmental BiologyResearch Article
researchProduct

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.

2012

Abstract Purpose Whether or not to biopsy the metastasis in recurrent breast cancer has become mired in controversy. Several studies have shown an important discordance of the immunohistochemical (IHC) determinations for ER, PR and HER2 between primary (PT) and recurrent tumors (RT). Yet it remains unknown within this what impact technical issues have. The aim of our study was to assess whether technical variability might have an impact on the concordance between PT and RT. Methods IHC determinations in paired biopsies from PT and RT were compared under routine vs study conditions. In the former, pathological analysis reproduced the conditions used in the routine of a University Pathology D…

OncologyAdultmedicine.medical_specialtyReceptor ErbB-2ConcordanceBone NeoplasmsBreast NeoplasmsMetastasisBreast cancerInternal medicineBiopsymedicineHumansPathologicalAgedRetrospective StudiesGynecologyAged 80 and overmedicine.diagnostic_testbusiness.industryConfoundingGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancerImmunohistochemistryReceptors EstrogenImmunohistochemistrySurgeryFemalebusinessReceptors ProgesteroneBreast (Edinburgh, Scotland)
researchProduct

Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast canc…

2021

Different immunohistochemical programmed death-ligand 1 (PD-L1) assays and scorings have been reported to yield variable results in triple-negative breast cancer (TNBC). We compared the analytical concordance and reproducibility of four clinically relevant PD-L1 assays assessing immune cell (IC) score, tumor proportion score (TPS), and combined positive score (CPS) in TNBC. Primary TNBC resection specimens (n = 104) were stained for PD-L1 using VENTANA SP142, VENTANA SP263, DAKO 22C3, and DAKO 28–8. PD-L1 expression was scored according to guidelines on virtual whole slide images by four trained readers. The mean PD-L1 positivity at IC-score ≥1% and CPS ≥1 ranged between 53% and 75% with th…

OncologyCPS combined positive scoreTC tumor cellsICI immune checkpoint inhibitorTriple Negative Breast NeoplasmsB7-H1 AntigenMedicineHER2 human epidermal growth factor receptor 2Triple-negative breast cancerRC254-282ICC intraclass correlation coefficientbiologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensGeneral MedicineMSI microsatellite instabilityImmunohistochemistrypCR pathological complete responsePFS progression-free survivalImmunohistochemistryOriginal ArticleIC-ScoreIC immune cellsIHC immunohistochemistryProgrammed deathPD-L1medicine.medical_specialtyConcordanceTNBC triple-negative breast cancerOS overall survivalBreast cancerTriple-negative breast cancerPD-L1Internal medicineTPS tumor proportion scoreBiomarkers TumorHumansProgrammed death-ligand 1Reproducibilitybusiness.industryReproducibility of Resultsmedicine.diseaseITT intention to treatCI confidence intervalPD-L1 programmed death-ligand 1biology.proteinSurgeryCPSbusinessKappaTMB tumor mutational burdenBreast
researchProduct